The GLP-1 (total) Control Pack consists of 3 levels of control, each containing known concentrations of amidated GLP-1 (9-36) peptide that are detected by the V-PLEX GLP-1 Total and V-PLEX Plus GLP-1 Total Kits (catalog # K1503PD, K1503PG). The GLP-1 (total) Controls 1, 2, and 3 are prepared by spiking the synthetic calibrator into a non-matrix based diluent. The controls are supplied as lyophilized powders.
-
-
Specifications
-
References
-
Documentation
|
Application(s)
|
|
Metabolic
|
|
|
Analyte(s)
|
|
GLP-1 (total)
|
|
|
Species
|
|
Human, Mouse, Non-human primate, Rat, Canine
|
|
|
Instrument(s)
|
|
SECTOR Imager 2400
,
MESO SECTOR S 600MM
,
SECTOR Imager 6000
,
MESO QuickPlex SQ 120MM
,
MESO QuickPlex SQ 120
,
MESO SECTOR S 600
|
|
|
LLOD (Sensitivity)
|
|
0.017 pM
|
|
|
Dynamic Range
|
|
0.017 - 120 pM
|
|
|
Recombinant standards
|
|
synthetic peptide
|
|
|
Usage Statement
|
|
For Research Use Only. Not for use in diagnostic procedures.
|
|
|
Storage Condition
|
|
2-8 °C
|
|
|
Gene ID(s)
|
|
2641, 14526, 24952, 403571, 102134567
|
|
|
UniProt ID(s)
|
|
P01275, P55095, P06883, P29794, A0A0D9RSY0
|
|
|
Schedule B Code
|
|
3822.19.0000
|
|
|
Title
|
Journal
|
Year
|
|
Beneficial effects of parenteral GLP-1 delivery by cell therapy in insulin-deficient streptozotocin diabetic mice.
|
|
|
|
Concomitant use of miglitol and mitiglinide as initial combination therapy in type 2 diabetes mellitus.
|
|
|
|
Consumption of buckwheat modulates the post-prandial response of selected gastrointestinal satiety hormones in individuals with type 2 diabetes mellitus.
|
|
|
|
Diacylglycerol Acyltransferase-1 (DGAT1) inhibition perturbs postprandial gut hormone release.
|
|
|
|
Effect of orally administered L. fermentum NCIMB 5221 on markers of metabolic syndrome: an in vivo analysis using ZDF rats
|
|
|
|
|
View All
|
|
Product Inserts
|
|
|
|
Certificate of analysis
|
|
|
Order Details
Catalog No
Size
Price in USD
Qty
Customer Service/Orders
Scientific/Technical Support
Instrument Support
Company Headquarters